FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978565535> ?p ?o ?g. }

• W1978565535 endingPage "117" @default.
• W1978565535 startingPage "109" @default.
• W1978565535 abstract "The majority of peptide-based cancer vaccines under development are for human leukocyte antigen (HLA)-A2- or -A24-positive patients. To overcome this limitation, we conducted a phase I clinical study of peptide vaccines designed for cancer patients with six different HLA-A types. Eligible patients were required to have failed prior standard cancer therapies and to be positive for the HLA-A2, -A24 or -A3 (A3, A11, A31 and A33) supertype. Three sets of 8 candidate peptides (24 peptides in total) were provided for vaccination to HLA-A2+, HLA-A24+ and HLA-A3+ patients, respectively. Personalization of the vaccination peptides from the candidate pool was made by considering the patients' HLA types and pre-existing levels of IgGs to the candidate peptides. Seventeen patients were enrolled in this study. The peptide vaccinations were well tolerated in all patients with no vaccine-related severe adverse events. Augmentation of cytotoxic T lymphocyte (CTL) or IgG responses specific to the vaccinated peptides was observed in 11 or 10 out of 13 cases tested, respectively. This new type of vaccine is recommended for phase II clinical trial because of its tolerability and the immune responses to the vaccinated peptides." @default.
• W1978565535 created "2016-06-24" @default.
• W1978565535 creator A5006133126 @default.
• W1978565535 creator A5011170833 @default.
• W1978565535 creator A5021998416 @default.
• W1978565535 creator A5026856725 @default.
• W1978565535 creator A5034428180 @default.
• W1978565535 creator A5038803008 @default.
• W1978565535 creator A5044424550 @default.
• W1978565535 creator A5050204003 @default.
• W1978565535 creator A5058463619 @default.
• W1978565535 creator A5078602721 @default.
• W1978565535 date "2010-12-02" @default.
• W1978565535 modified "2023-09-25" @default.
• W1978565535 title "Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer" @default.
• W1978565535 cites W1986050959 @default.
• W1978565535 cites W1991150744 @default.
• W1978565535 cites W2001649054 @default.
• W1978565535 cites W2004227185 @default.
• W1978565535 cites W2029993034 @default.
• W1978565535 cites W2037665874 @default.
• W1978565535 cites W2061716303 @default.
• W1978565535 cites W2066440404 @default.
• W1978565535 cites W2079542677 @default.
• W1978565535 cites W2095777640 @default.
• W1978565535 cites W2097131997 @default.
• W1978565535 cites W2098149634 @default.
• W1978565535 cites W2124129321 @default.
• W1978565535 cites W2128195933 @default.
• W1978565535 cites W2166831581 @default.
• W1978565535 cites W4255758041 @default.
• W1978565535 doi "https://doi.org/10.3892/etm.2010.177" @default.
• W1978565535 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3440674" @default.
• W1978565535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22977478" @default.
• W1978565535 hasPublicationYear "2010" @default.
• W1978565535 type Work @default.
• W1978565535 sameAs 1978565535 @default.
• W1978565535 citedByCount "3" @default.
• W1978565535 countsByYear W19785655352017 @default.
• W1978565535 countsByYear W19785655352018 @default.
• W1978565535 countsByYear W19785655352019 @default.
• W1978565535 crossrefType "journal-article" @default.
• W1978565535 hasAuthorship W1978565535A5006133126 @default.
• W1978565535 hasAuthorship W1978565535A5011170833 @default.
• W1978565535 hasAuthorship W1978565535A5021998416 @default.
• W1978565535 hasAuthorship W1978565535A5026856725 @default.
• W1978565535 hasAuthorship W1978565535A5034428180 @default.
• W1978565535 hasAuthorship W1978565535A5038803008 @default.
• W1978565535 hasAuthorship W1978565535A5044424550 @default.
• W1978565535 hasAuthorship W1978565535A5050204003 @default.
• W1978565535 hasAuthorship W1978565535A5058463619 @default.
• W1978565535 hasAuthorship W1978565535A5078602721 @default.
• W1978565535 hasBestOaLocation W19785655351 @default.
• W1978565535 hasConcept C121608353 @default.
• W1978565535 hasConcept C126322002 @default.
• W1978565535 hasConcept C143998085 @default.
• W1978565535 hasConcept C147483822 @default.
• W1978565535 hasConcept C147969180 @default.
• W1978565535 hasConcept C154317977 @default.
• W1978565535 hasConcept C167672396 @default.
• W1978565535 hasConcept C188280979 @default.
• W1978565535 hasConcept C195616568 @default.
• W1978565535 hasConcept C197934379 @default.
• W1978565535 hasConcept C202751555 @default.
• W1978565535 hasConcept C203014093 @default.
• W1978565535 hasConcept C22070199 @default.
• W1978565535 hasConcept C2776789287 @default.
• W1978565535 hasConcept C2777701055 @default.
• W1978565535 hasConcept C2778375690 @default.
• W1978565535 hasConcept C2778378633 @default.
• W1978565535 hasConcept C2780868878 @default.
• W1978565535 hasConcept C55493867 @default.
• W1978565535 hasConcept C71924100 @default.
• W1978565535 hasConcept C86803240 @default.
• W1978565535 hasConcept C8891405 @default.
• W1978565535 hasConceptScore W1978565535C121608353 @default.
• W1978565535 hasConceptScore W1978565535C126322002 @default.
• W1978565535 hasConceptScore W1978565535C143998085 @default.
• W1978565535 hasConceptScore W1978565535C147483822 @default.
• W1978565535 hasConceptScore W1978565535C147969180 @default.
• W1978565535 hasConceptScore W1978565535C154317977 @default.
• W1978565535 hasConceptScore W1978565535C167672396 @default.
• W1978565535 hasConceptScore W1978565535C188280979 @default.
• W1978565535 hasConceptScore W1978565535C195616568 @default.
• W1978565535 hasConceptScore W1978565535C197934379 @default.
• W1978565535 hasConceptScore W1978565535C202751555 @default.
• W1978565535 hasConceptScore W1978565535C203014093 @default.
• W1978565535 hasConceptScore W1978565535C22070199 @default.
• W1978565535 hasConceptScore W1978565535C2776789287 @default.
• W1978565535 hasConceptScore W1978565535C2777701055 @default.
• W1978565535 hasConceptScore W1978565535C2778375690 @default.
• W1978565535 hasConceptScore W1978565535C2778378633 @default.
• W1978565535 hasConceptScore W1978565535C2780868878 @default.
• W1978565535 hasConceptScore W1978565535C55493867 @default.
• W1978565535 hasConceptScore W1978565535C71924100 @default.
• W1978565535 hasConceptScore W1978565535C86803240 @default.
• W1978565535 hasConceptScore W1978565535C8891405 @default.
• W1978565535 hasIssue "1" @default.

• next